Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Horst

Showing results (11-20 of 221) with videos related to

Pageof 23
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 7, 2011
Toward the prognostic significance and therapeutic potential of HER3 receptor tyrosine kinase in human colon cancerAbdelhamid Beji, David Horst, Jutta Engel, et al.
Cancer|August 7, 2009
Invasion associated up-regulation of nuclear factor kappaB target genes in colorectal cancerDavid Horst, Jan Budczies, Thomas Brabletz, et al.
Pathology, Research and Practice|May 16, 2022
AURKA is a prognostic biomarker for good overall survival in stage II colorectal cancer patientsPeter Jung, David Horst, Thomas Kirchner, et al.
Journal of Hematopathology|June 3, 2026
From suspected lymphoma to self-limiting lymphadenitis: Kikuchi-Fujimoto disease in focusJulian Rieck, Carsten Dittmayer, Martin Janz, et al.
Journal of Cancer|October 11, 2019
RBP7 is a clinically prognostic biomarker and linked to tumor invasion and EMT in colon cancerManal Elmasry, Lydia Brandl, Jutta Engel, et al.
Cellular and Molecular Gastroenterology and Hepatology|April 19, 2020
Characterization of a p53/miR-34a/CSF1R/STAT3 Feedback Loop in Colorectal CancerXiaolong Shi, Markus Kaller, Matjaz Rokavec, et al.
Cancer|March 21, 2009
The intratumoral distribution of nuclear beta-catenin is a prognostic marker in colon cancerDavid Horst, Simone Reu, Lydia Kriegl, et al.
Haematologica|March 11, 2005
The Southeast Asian 12.5 KB (delta-beta) degrees-deletion: a common beta-thalassemia in Mon-Khmer groups (Lao Theung) of South LaosTorpong Sanguansermsri, Sourideth Sengchanh, David Horst, et al.
Oncogene|October 30, 2024
GPA33 expression in colorectal cancer can be induced by WNT inhibition and targeted by cellular therapyTeresa Börding, Tobias Janik, Philip Bischoff, et al.
Journal of Translational Medicine|November 25, 2010
LEF-1 and TCF4 expression correlate inversely with survival in colorectal cancerLydia Kriegl, David Horst, Jana A Reiche, et al.
Pageof 23

Showing results (11-20 of 221) with videos related to

Sort By:
Pageof 23
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 7, 2011
Toward the prognostic significance and therapeutic potential of HER3 receptor tyrosine kinase in human colon cancerAbdelhamid Beji, David Horst, Jutta Engel, et al.
Cancer|August 7, 2009
Invasion associated up-regulation of nuclear factor kappaB target genes in colorectal cancerDavid Horst, Jan Budczies, Thomas Brabletz, et al.
Pathology, Research and Practice|May 16, 2022
AURKA is a prognostic biomarker for good overall survival in stage II colorectal cancer patientsPeter Jung, David Horst, Thomas Kirchner, et al.
Journal of Hematopathology|June 3, 2026
From suspected lymphoma to self-limiting lymphadenitis: Kikuchi-Fujimoto disease in focusJulian Rieck, Carsten Dittmayer, Martin Janz, et al.
Journal of Cancer|October 11, 2019
RBP7 is a clinically prognostic biomarker and linked to tumor invasion and EMT in colon cancerManal Elmasry, Lydia Brandl, Jutta Engel, et al.
Cellular and Molecular Gastroenterology and Hepatology|April 19, 2020
Characterization of a p53/miR-34a/CSF1R/STAT3 Feedback Loop in Colorectal CancerXiaolong Shi, Markus Kaller, Matjaz Rokavec, et al.
Cancer|March 21, 2009
The intratumoral distribution of nuclear beta-catenin is a prognostic marker in colon cancerDavid Horst, Simone Reu, Lydia Kriegl, et al.
Haematologica|March 11, 2005
The Southeast Asian 12.5 KB (delta-beta) degrees-deletion: a common beta-thalassemia in Mon-Khmer groups (Lao Theung) of South LaosTorpong Sanguansermsri, Sourideth Sengchanh, David Horst, et al.
Oncogene|October 30, 2024
GPA33 expression in colorectal cancer can be induced by WNT inhibition and targeted by cellular therapyTeresa Börding, Tobias Janik, Philip Bischoff, et al.
Journal of Translational Medicine|November 25, 2010
LEF-1 and TCF4 expression correlate inversely with survival in colorectal cancerLydia Kriegl, David Horst, Jana A Reiche, et al.
Pageof 23